# Shenzhen Force of Life Science Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-force-of-life-science-co

- Industry: Pharmaceuticals
- Headquarters: Shenzhen, China
- Website: www.ionovabio.com
- Total disclosed funding: $18M
- Latest round: Series A (Oct 15, 2019)
- Investors on record: 2

## About

Established in 2016 and based in Shenzhen, China, Shenzhen Force of Life Science Co., Ltd. operates as a developer of new drugs that focuses on the production and development of oncology drugs. The founder of the company, Yongkun Sun, worked as the vice president of Moshadong R&D(China)Co.,Ltd., and the CMO, Johannes Nippgen was the Head of R&D, Merck Pharma R&D, China.

The company develops targeted and immunotherapies for more effective cancer treatment. The company develops tumor-targeted drugs and tumor immunomodulatory drugs designed to provide solutions to oncology, immunity, and cardiac metabolic diseases. The company's research wing, Touchstone Translational Research Institute, enables the company to establish both internal disease biology-driven drug discovery programs.

## Funding rounds

- Series A, Oct 15, 2019, $18M — Lilly Asia Ventures, DYEE Capital

## Investors

- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series A
- DYEE Capital (https://capitalatlas.ai/funds/dyee-capital) — Series A